Published in Ann Transl Med on December 01, 2016
Human skin wounds: a major and snowballing threat to public health and the economy. Wound Repair Regen (2009) 7.29
Platelet-rich plasma: Growth factor enhancement for bone grafts. Oral Surg Oral Med Oral Pathol Oral Radiol Endod (1998) 7.05
Platelet-rich plasma: from basic science to clinical applications. Am J Sports Med (2009) 4.31
Platelet-rich plasma (PRP): what is PRP and what is not PRP? Implant Dent (2001) 3.73
A multicenter, randomized, controlled clinical trial evaluating the use of dehydrated human amnion/chorion membrane allografts and multilayer compression therapy vs. multilayer compression therapy alone in the treatment of venous leg ulcers. Wound Repair Regen (2015) 2.18
The efficacy and safety of Dermagraft in improving the healing of chronic diabetic foot ulcers: results of a prospective randomized trial. Diabetes Care (2003) 2.09
Properties of the amniotic membrane for potential use in tissue engineering. Eur Cell Mater (2008) 2.01
Graftskin, a human skin equivalent, is effective in the management of noninfected neuropathic diabetic foot ulcers: a prospective randomized multicenter clinical trial. Diabetes Care (2001) 1.97
Chronic wound pathogenesis and current treatment strategies: a unifying hypothesis. Plast Reconstr Surg (2006) 1.96
Concise review: role of mesenchymal stem cells in wound repair. Stem Cells Transl Med (2012) 1.92
A prospective, randomized, controlled trial of autologous platelet-rich plasma gel for the treatment of diabetic foot ulcers. Ostomy Wound Manage (2006) 1.82
Amniotic membrane transplantation. Br J Ophthalmol (1999) 1.82
Classification and treatment of chronic nonhealing wounds. Successful treatment with autologous platelet-derived wound healing factors (PDWHF). Ann Surg (1986) 1.61
Use of platelet growth factors in treating wounds and soft-tissue injuries. Acta Dermatovenerol Alp Pannonica Adriat (2007) 1.55
A retrospective clinical study of 188 consecutive patients to examine the effectiveness of a biologically active cryopreserved human skin allograft (TheraSkin®) on the treatment of diabetic foot ulcers and venous leg ulcers. Foot Ankle Spec (2010) 1.41
The role of fibroblasts in tissue engineering and regeneration. Br J Dermatol (2007) 1.23
Evidence-based management strategies for treatment of chronic wounds. Eplasty (2009) 1.21
Wound Care Outcomes and Associated Cost Among Patients Treated in US Outpatient Wound Centers: Data From the US Wound Registry. Wounds (2012) 1.18
Human mesenchymal stem cell grafts enhance normal and impaired wound healing by recruiting existing endogenous tissue stem/progenitor cells. Stem Cells Transl Med (2012) 1.14
A metabolically active human dermal replacement for the treatment of diabetic foot ulcers. Artif Organs (1997) 1.11
Umbilical cord blood: a unique source of pluripotent stem cells for regenerative medicine. Curr Stem Cell Res Ther (2007) 1.05
Treatment of venous leg ulcers with Dermagraft. Eur J Vasc Endovasc Surg (2004) 1.01
The efficacy and safety of Grafix(®) for the treatment of chronic diabetic foot ulcers: results of a multi-centre, controlled, randomised, blinded, clinical trial. Int Wound J (2014) 1.00
Systematic review of economic evaluations of human cell-derived wound care products for the treatment of venous leg and diabetic foot ulcers. BMC Health Serv Res (2009) 0.99
The use of a collagen sponge/living cell composite material to treat donor sites in burn patients. Burns (2003) 0.99
Challenges in the Treatment of Chronic Wounds. Adv Wound Care (New Rochelle) (2015) 0.97
Bilayered bioengineered skin substitute (Apligraf): a review of its use in the treatment of venous leg ulcers and diabetic foot ulcers. BioDrugs (2002) 0.96
Stem Cells and Healing: Impact on Inflammation. Adv Wound Care (New Rochelle) (2013) 0.95
Apligraf in the treatment of neuropathic diabetic foot ulcers. Int J Low Extrem Wounds (2009) 0.95
Modification of fibroblast gamma-interferon responses by extracellular matrix. J Invest Dermatol (2001) 0.94
A review of a bi-layered living cell treatment (Apligraf) in the treatment of venous leg ulcers and diabetic foot ulcers. Clin Interv Aging (2007) 0.94
Healing of chronic foot ulcers in diabetic patients treated with a human fibroblast-derived dermis. J Foot Ankle Surg (2002) 0.93
Scientific and clinical support for the use of dehydrated amniotic membrane in wound management. Wounds (2012) 0.89
Clinical and economic impact of Apligraf for the treatment of nonhealing venous leg ulcers. Int J Dermatol (2003) 0.88
A retrospective analysis of a human cellular repair matrix for the treatment of chronic wounds. Ostomy Wound Manage (2013) 0.87
Treatment of chronic diabetic lower extremity ulcers with advanced therapies: a prospective, randomised, controlled, multi-centre comparative study examining clinical efficacy and cost. Int Wound J (2015) 0.84
A prospective, multicentre, randomised controlled study of human fibroblast-derived dermal substitute (Dermagraft) in patients with venous leg ulcers. Int Wound J (2013) 0.83
A pilot study to evaluate the safety and clinical performance of Leucopatch, an autologous, additive-free, platelet-rich fibrin for the treatment of recalcitrant chronic wounds. Int J Low Extrem Wounds (2011) 0.81
A prospective comparison of diabetic foot ulcers treated with either a cryopreserved skin allograft or a bioengineered skin substitute. Wounds (2011) 0.80
Grafix(®), a Cryopreserved Placental Membrane, for the Treatment of Chronic/Stalled Wounds. Adv Wound Care (New Rochelle) (2015) 0.79
Use of an autologous leucocyte and platelet-rich fibrin patch on hard-to-heal DFUs: a pilot study. J Wound Care (2015) 0.78
Dermagraft: Use in the Treatment of Chronic Wounds. Adv Wound Care (New Rochelle) (2012) 0.78
Systematic review of the use of platelet-rich plasma in aesthetic dermatology. J Cosmet Dermatol (2015) 0.77
Effect of autologous platelet-rich plasma application on cutaneous wound healing in dogs. J Vet Sci (2016) 0.77
A Single-center, Retrospective Study of Cryopreserved Umbilical Cord for Wound Healing in Patients Suffering From Chronic Wounds of the Foot and Ankle. Wounds (2016) 0.76
A retrospective study of cryopreserved umbilical cord as an adjunctive therapy to promote the healing of chronic, complex foot ulcers with underlying osteomyelitis. Wound Repair Regen (2016) 0.76
Biological approach for the management of non-healing diabetic foot ulcers. J Tissue Viability (2016) 0.76
Use of a meshed bilayered cellular matrix to treat a venous ulcer. Adv Skin Wound Care (2002) 0.76
Comparison of the Effects of Plateletrich Plasma Prepared in Various Forms on the Healing of Dermal Wounds in Rats. Wounds (2016) 0.76
A single-centre, retrospective study of cryopreserved umbilical cord/amniotic membrane tissue for the treatment of diabetic foot ulcers. J Wound Care (2016) 0.76